Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
40.12
-1.82 (-4.34%)
Nov 17, 2026, 3:00 PM CST
| Market Cap | 6.95B -29.6% |
| Revenue (ttm) | 1.30B -2.0% |
| Net Income | 272.52M +12.9% |
| EPS | 1.58 +15.2% |
| Shares Out | 173.13M |
| PE Ratio | 25.40 |
| Forward PE | 25.73 |
| Dividend | 0.49 (1.22%) |
| Ex-Dividend Date | Jun 2, 2026 |
| Volume | 1,451,493 |
| Open | 42.03 |
| Previous Close | 41.94 |
| Day's Range | 39.91 - 42.03 |
| 52-Week Range | 38.71 - 80.48 |
| Beta | 0.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 28, 2026 |